Arzneiverordnungen 2022 im Überblick
- 1 January 2023
- book chapter
- Published by Springer Nature
- p. 3-28
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Strategies that delay or prevent the timely availability of affordable generic drugs in the United StatesBlood, 2016
- High-Cost Generic Drugs — Implications for Patients and PolicymakersNew England Journal of Medicine, 2014
- How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to ConsiderThe AAPS Journal, 2013
- Patented Drug Extension Strategies on Healthcare Spending: A Cost-Evaluation AnalysisPLOS Medicine, 2013
- Why rare diseases are an important medical and social issueThe Lancet, 2008
- The burden of rheumatoid arthritis and access to treatment: uptake of new therapiesThe European Journal of Health Economics, 2007
- Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countriesHealth Policy, 2007
- International comparison of generic medicine pricesCurrent Medical Research and Opinion, 2007
- International Differences in Drug PricesAnnual Review of Public Health, 2004
- Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?Health Affairs, 2003